Wayne State University Division of Research

Wayne State researchers receive NSF funding to develop COVID-19 risk-prediction system

Newswise — DETROIT – Since the initial case of COVID-19 was diagnosed at the end of December 2019, there have been more than 2.3 million cases reported in the United States, causing more than 120,000 deaths as of June 23. Around the globe, there have been over 9.2 million cases reported, with nearly 477,000 deaths.

The outbreak of COVID-19 has significantly affected society as a whole and caused the cancellation of many events, conferences, classes and more around the world. With the continued increase in cases, there is an urgent need for a risk-prediction and update system so that individuals and various entities can be aware of the potential risk of infection when traveling locally, nationally or abroad.

Researchers from Wayne State University’s College of Engineering and the Henry Ford Health System are teaming up to design and implement such a system — and taking on several challenges in doing so. According to Weisong Shi, Ph.D., associate dean of research and graduate studies and professor of computer science at Wayne State, the team will work together to derive a system that can assess infection risk at different levels, such as individually or at large-event and institution levels. Shi also noted that the system must dynamically update the risk level based on the latest outbreak reports, as well as be able to preserve user sensitive data while sharing adequate and appropriate data that will allow risk-level calculation.

Shi and his team are attacking these challenges with the help of a $150,000 RAPID grant from the National Science Foundation (NSF), and a $10,000 Google Cloud Platform grant. The project, CORPUS: An Edge Intelligence-assisted Multi-Granularity COVID-19 Risk Prediction and Update System, will design and implement a system that includes a mobile app running on personal phones, as well as a large-scale distributed protocol behind the app that collects and updates the information.

“CORPUS will build a multigranularity risk-analysis model that will cover fine-grained personal risk; small, clustered meeting risk; and coarse-grained large clustered event/ organizational risk,” said Shi. “In addition, CORPUS will employ a data-propagation protocol to build and update the risk-analysis model.”

The data could include spatial data (such as a GPS signal), temporal data (such as calendar events), as well as input from the user (such as meeting with a specific person). To insure confidentiality of personal information, CORPUS will leverage privacy-preserving algorithms such as node-level feature pooling and anonymous parameters of the model instead of raw user data when multigranularity models request personal risk information.

“The great thing about CORPUS is that it will have the potential to meet the needs of many by leveraging personalized information and edge intelligence,” said Shi. “For a group or an organization, CORPUS will provide risk-related information to help them judge the feasibility of holding a meeting or an event during an outbreak, especially for large-scale international events, such as conferences and more.”

In addition, the system can proactively aid users in acting based on the risk information provided to reduce the spread of COVID-19. CORPUS will be able to assist governments to perceive the risk of infection in their jurisdictions, and thus guide infection prevention and control for effective governance.

The Google Cloud Platform will be leveraged to train the risk prediction and analysis models of CORPUS, as well as to host the cloud services for data storage.

Shi’s collaborators include Ming Dong, Ph.D., professor of Computer Science at Wayne State University, and Marcus Zervos, M.D., infectious disease specialist at Henry Ford Health System and assistant dean of global affairs in the Wayne State School of Medicine.

The NSF Rapid Response Research (RAPID) funding mechanism allows the NSF to receive and review proposals having a severe urgency with regard to availability of or access to data, facilities or specialized equipment, as well as quick-response research on natural or anthropogenic disasters and similar unanticipated events, e.g., COVID-19.

The NSF award number for this project is 2027251.

# # #

Wayne State University is one of the nation’s pre-eminent public research institutions in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, the state of Michigan and throughout the world. For more information about research at Wayne State University, visit http://www.research.wayne.edu.




Filters close

Showing results

110 of 2813
Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 12:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Imitation May Be a Sincere Form of Treatment
Released: 5-Aug-2020 12:35 PM EDT
Imitation May Be a Sincere Form of Treatment
University of California San Diego Health

The National Institutes of Health will soon launch a phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

Newswise: NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring
Released: 5-Aug-2020 12:30 PM EDT
NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring
National Institute of Biomedical Imaging and Bioengineering

NIH has launched an ambitious effort to use artificial intelligence, computation, and medical imaging to enable early disease detection, inform successful treatment strategies, and predict individual disease outcomes of COVID-19.


Showing results

110 of 2813

close
3.61667